Elderly Clinical Trial - The State of Play in Picardy of the Knowledge of

Status Completed

Clinical Trial Summary

In 2010, the French population over 75 years of age was 9%; It will be 13% in 2030 and 19% in 2050 according to estimates. The incidence of falls is high in the elderly population, with at least one fall per year for one-third of the over-65s and for half of the over-80s. These data are consistent with the international medical literature, particularly in Japan, the United States and France, with a high rate of recurrence from the first fall. Falling is a complex phenomenon that is of great importance in terms of morbidity and mortality since it can be followed by serious complications: failure to recover, recurrences, trauma (fractures, hematomas, wounds), complications of decubitus and ulcers, Immobilization, loss of autonomy, hospitalization, institutionalization, psychological complications (post-fall syndrome, depressive syndrome), death.

Fall risk factors are well known and described and relayed by learned societies of geriatrics and medical literature. In addition, HAS reported on this issue in 2009.

The French Society of Geriatrics and Gerontology (SFGG) defines fragility as a clinical syndrome that reflects a decrease in reserve physiological capacities that alters the coping mechanisms of stress. Its clinical expression is modulated by comorbidities and psychological, social, economic and behavioral factors. Frailty syndrome is a risk marker for mortality and pejorative events, including disability, falls, hospitalization and institutionalization. The fall and its complications are closely related to the fragility syndrome. The very fragile patient must take an active part in his own care. He is the first advocate of fall prevention.

On the other hand medical desertification and the low number of geriatricians makes this implication problematic even more so if the person is isolated or has cognitive impairment. Nevertheless, it is important to make the patient actor of his own prevention. This is the first study to describe the knowledge of older adults about their own risk of falling.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03132857
Study type	Observational
Source	Centre Hospitalier Universitaire, Amiens
Contact
Status	Completed
Phase
Start date	March 12, 2017
Completion date	December 16, 2017

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05531396` - Agility Training on Physical Performance, Cognitive Function and Brain Activities in Elderly	N/A
Completed	`NCT03580447` - The Effect of Citrus Extract on Oxidative Stress	N/A
Recruiting	`NCT04096547` - Rivaroxaban in Elderly NVAF Patients With or Without Renal Impairment
Completed	`NCT03339791` - Sleeve Versus Bypass in Older Patients: a Randomized Controlled Trial	N/A
Completed	`NCT03566719` - Effect of an Exercise Program on Risk of Fall in a Community Dwelling Older Adults	N/A
Completed	`NCT02138968` - Clinical and Economic Assessment of a Pre-frail Screening Program	N/A
Completed	`NCT01368029` - Safety of Lactobacillus Rhamnosus GG Vs. Placebo in Elderly Subjects Receiving Trivalent Inactivated Influenza Vaccine	Phase 1
Not yet recruiting	`NCT01182961` - The Use of Virtual Reality for the Gait Training of Elderly Fallers	N/A
Completed	`NCT00961012` - The Big Squeeze (Lessening the Big Squeeze: The Effect of the Trunk Release on Interface Pressures of Individuals Seated in a High Fowler's Positions)	N/A
Completed	`NCT01899586` - Mechanisms and Functional Outcomes of Exercise Progression Models in the Elderly	N/A
Completed	`NCT00748683` - Development of an Integrated Health Care Environment for Elderly With RFID Technology	Phase 0
Completed	`NCT00533065` - Effects of Donepezil on Deficits Associated With Age-Related Decrease of Growth Hormone	N/A
Completed	`NCT00798668` - The Body's Response to Food Intake in Trained, Older Adults	N/A
Completed	`NCT00324701` - Telepsychology-Service Delivery for Depressed Elderly Veterans	N/A
Completed	`NCT00217113` - An Intervention to Preserve Functional Status and Independence Among Community Dwelling Elderly	N/A
Completed	`NCT03666793` - Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care	N/A
Recruiting	`NCT06030804` - Perioperative Dexmedetomidine and Long-term Survival After Cancer Surgery	N/A
Recruiting	`NCT05014750` - Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
Completed	`NCT05021432` - Virtual Reality And Task Oriented Circuit Training Among Elderly Population	N/A
Active, not recruiting	`NCT04132492` - AGNES - Aging Nephropathy Study, a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The State of Play in Picardy of the Knowledge of the Elderly at Risk of Falling at Home in Terms of Prevention and Evaluation. — Epic-SaPE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms